Challenge Potential reason(s) Potential consequence(s)
Reduced financial support / philanthropy
Limited donations given personal budget constraints or loss of revenues from in person event cancellations and economic uncertainties
Less resources to offer patients and families, less funding for treatment and non-treatment related expenses New programs delayed or cancelled Grant opportunities reduced, delayed or cancelled
New patients not recruited to sponsored clinical trials
Resources diverted to COVID-19 Perceived risk to patients Increased anxiety and fear among patients and families Reduced options for treatment of relapsed/refractory disease, potential reduction in overall survival
Sponsored programs delayed or cancelled
Research and development resources diverted Research labs closed Workers furloughed Pressure from donors and supporters to move programs forward Unanticipated additional costs
Reduced community engagement Community focus on COVID-19 Reduced philanthropy
Limitations in available housing and transportation Restrictions in place from COVID-19 Impact on clinical care
Reduced lobbying for pediatric cancer Government focus on COVID-19 Less government awareness and earmarked funding
National and international pediatric oncology meetings cancelled or postponed Missed opportunities for engagement with other stakeholders Collaborative partnerships not developed